article_metadata: Kaleen N Hayes Ulrike Baschant Barbara Hauser Andrea M Burden Elizabeth M Winter
article_metadata: 10.3389/fendo.2021.782118
article_metadata: Front Endocrinol (Lausanne)
article_metadata: 2021 Dec 15;12:782118.
article_metadata: anti-resorptive treatment bisphosphonates bone density bone density conservation agents bone fractures glucocorticoid-induced osteoporosis glucocorticoids teriparatide
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34975756/
article_metadata: Bone Density / drug effects Bone Density Conservation Agents / administration & dosage Glucocorticoids / adverse effects Osteoporosis / chemically induced Osteoporosis / drug therapy Withholding Treatment
article_metadata: Bone Density / drug effects Bone Density Conservation Agents / administration & dosage Glucocorticoids / adverse effects Osteoporosis / chemically induced Osteoporosis / drug therapy Withholding Treatment Case Reports Review Bone Density / physiology Female Fractures, Bone / diagnostic imaging Fractures, Bone / prevention & control Glucocorticoids / administration & dosage Humans Lupus Erythematosus, Systemic / diagnostic imaging Lupus Erythematosus, Systemic / drug therapy Middle Aged Osteoporosis / diagnostic imaging Time-to-Treatment Bone Density Conservation Agents Glucocorticoids
article_metadata: PMC8715727
article_metadata: 34975756
article_metadata: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
article_metadata: 2021